Search
for
Sort by
Research 61–90 of 1000+
- Long-term physiological trends and their drivers: linking hair hormone concentrations with telemetry data in GPS-collared Serengeti wildebeest
- Gender-Affirming Hormone Therapy for Transgender Females
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. in Basal Cell Carcinomas
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Neuroendocrine Controls of Keratin Expression in Human Skin
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Treatment of hyperandrogenism in women
- Minireview: vitamin D receptor: new assignments for an already busy receptor. - eScholarship
- Vitamin D and the skin: Focus on a complex relationship: A review
- Targets to treat androgen excess in polycystic ovary syndrome
- Metabolism and skin diseases
- Diseases of the Hair and Nails
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Further Clinical Evidence for the Effect of IGF-1 on Hair Growth and Alopecia
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Androgenetic Alopecia
- Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria
- Telogen effluvium
- Polycystic ovary syndrome
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Endocrine-skin interactions
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome